Sepsis Diagnostics Market, by Product Type (Blood Culture Media, Assays & Reagents, Instruments, and Software), by Method (Automated Diagnostics and Conventional Diagnostics), by Pathogen (Bacterial Sepsis {Gram-Negative Bacterial Sepsis and Gram-Positive

Sepsis Diagnostics Market, by Product Type (Blood Culture Media, Assays & Reagents, Instruments, and Software), by Method (Automated Diagnostics and Conventional Diagnostics), by Pathogen (Bacterial Sepsis {Gram-Negative Bacterial Sepsis and Gram-Positive Bacterial Sepsis}, Fungal Sepsis, and Others), by Technology (Microbiology, Molecular Diagnostics, Immunoassays, and Flow Cytometry), by End User (Hospitals, Pathology & Reference Laboratories, and Research Laboratories & Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Sepsis is a condition wherein the body’s response to infection trigger an inflammation reaction throughout the body. Immune system releases inflammatory chemicals into the bloodstream to clear out pathogens from the body but instead these chemicals cause cascade of reactions that result in organ damage and may be fatal. Few of the symptoms of sepsis include low blood pressure, mental confusion, fever, increased heart rate, and difficulty in breathing. Sepsis may be caused by infectious agents such as bacteria, virus, and fungi. Several factors that increase the risk of sepsis include old age, diabetes, liver disease, use of antibiotics, and usage of invasive medical devices such as catheters.

Market Dynamics

Market players are conducting clinical trials for developing more efficient diagnostic systems for sepsis, which could contribute to the growth of the market over the forecast period. For instance, in February 2021, Inflammatix, Inc., a U.S. based diagnostics company initiated clinical trial study for their product HostDx Sepsis with 1500 participants which is expected to be completed by November 2021. This clinical study investigates the performance of HostDx Sepsis diagnostic test in the diagnosis and prognosis of patients with suspected sepsis.

Market players are focusing on launch of products, which is expected to strengthen their position in the global sepsis diagnostics market. For instance, in July 2018, Thermo Fisher Scientific Inc., a U.S. based diagnostics solutions provider launched its product B•R•A•H•M•S PCT which is a direct POC (Point of Care) assay for early detection of sepsis.

Market players are involved in expanding their presence globally, by entering into collaboration with other companies in order to enhance distribution, this is expected to drive the growth of the global sepsis diagnostics market. For instance, in May 2021, BARDA (Biomedical Advanced Research and Development Authority) and Beckman Coulter Inc., a U.S. based biomedical testing solutions provider entered into a strategic collaboration for development of a diagnostic algorithm for early detection of sepsis in COVID-19 patients.

Key features of the study:
This report provides an in-depth analysis of global sepsis diagnostics market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global Sepsis Diagnostics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include BioMérieux SA, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics AG, Luminex Corporation, CytoSorbents Corporation, Becton Dickinson Company, Danaher Corporation, Axis-Shield Diagnostics, T2 Biosystems, EKF Diagnostics, Immunexpress Inc., Response Biomedical Corporation, and Bruker Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global sepsis diagnostics market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sepsis diagnostics market
Detailed Segmentation:
Global Sepsis Diagnostics Market, By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
Global Sepsis Diagnostics Market, By Method:
Automated Diagnostics
Conventional Diagnostics
Global Sepsis Diagnostics Market, By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
Global Sepsis Diagnostics Market, By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Global Sepsis Diagnostics Market, By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
Global Sepsis Diagnostics Market, By Region:
North America
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country:
U.S.
Canada
Latin America
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Method:
Automated Diagnostics
Conventional Diagnostics
By Pathogen:
Bacterial Sepsis
Gram-Negative Bacterial Sepsis
Gram-Positive Bacterial Sepsis
Fungal Sepsis
Others
By Technology:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
By End User:
Hospitals
Pathology & Reference Laboratories
Research Laboratories & Academic Institutes
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
BioMérieux SA*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Thermo Fisher Scientific
Abbott Laboratories
Roche Diagnostics AG
Luminex Corporation
CytoSorbents Corporation
Becton Dickinson Company
Danaher Corporation
Axis-Shield Diagnostics
T2 Biosystems
EKF Diagnostics
Immunexpress Inc.
Response Biomedical Corporation
Bruker Corporation
“*” marked represents similar segmentation in other categories in the respective section.